Fifth Third Bancorp
ATOS icon

Fifth Third Bancorp’s Atossa Therapeutics ATOS Stock Holding History

Fifth Third Bancorp’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3
Closed – – 2163
2019
Q2 		$0 Hold
3
– – ﹤0.01% 2259
2019
Q1 		$0 Hold
3
– – ﹤0.01% 2150
2018
Q4 		$0 Hold
3
– – ﹤0.01% 2217
2018
Q3 		$0 Hold
3
– – ﹤0.01% 2186
2018
Q2 		$0 Buy
+3
New +$161 ﹤0.01% 2265

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Fifth Third Bancorp's ATOS Position: Q3 2019 in Review

Fifth Third Bancorp sold out of Atossa Therapeutics (ATOS) in Q3 2019, closing a stake of 3 shares.

Fifth Third Bancorp first reported a position in ATOS in Q2 2018 and held it in 5 quarters. The position peaked at $0 in Q2 2019. 15 funds tracked by Wall St. Rank hold ATOS as of Q3 2019.

  • Fifth Third Bancorp reported no remaining Atossa Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 3 Atossa Therapeutics shares in Q3 2019.
  • Fifth Third Bancorp first reported a position in Atossa Therapeutics in Q2 2018 and held it in 5 quarters.
  • Fifth Third Bancorp's Atossa Therapeutics position peaked at $0 in Q2 2019.
  • 15 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2019.

Based on Fifth Third Bancorp's 13F filing for Q3 2019, filed 14 Nov 2019.